Paraskevas Lilly-Rose MD - 10017 New York City, NY

Business Name: Paraskevas Lilly-Rose MD
Categorized In: Doctors
Address: 800 2nd Avenue Room 815, New York City, NY 10017
Phone Number: (212) 803-6005
Contact Person: Lilly-Rose Paraskevas
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Weinrauch Y MD - New York City, NY 10017
Silverstein Daniel MD - New York City, NY 10017
Pastore Suzanne MD - New York City, NY 10017
Gallina Jason M MD - New York City, NY 10017
Rothenberg Mace L MD - New York City, NY 10017
Kokayi Kamau MD - New York City, NY 10017
Kernberg Otto F MD - New York City, NY 10017
Jeffrey Doctor Crespin Md - New York City, NY 10017
Gray Michael R MD - New York City, NY 10017
New York Midtown Ob/Gyn - New York City, NY 10017
New York Eye Specialist - New York City, NY 10017
Lind Viviane MD - New York City, NY 10017
Mc Nutt Edith MD - New York City, NY 10017
Mazlin - New York City, NY 10017
De Leon Antonio Y - New York City, NY 10017
P C My Ophthalmologist - New York City, NY 10017
One Medical Group - New York City, NY 10017
NY Arthritis Clinic Pc - New York City, NY 10017
Ranganathan Pavithra MD - New York City, NY 10017
Beasley Robert W MD - New York City, NY 10017

Paraskevas Lilly-Rose MD provides professional Doctors from its single location at the coordinates 40.750309,-73.971765.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 800 2nd Avenue Room 815, New York City, New York 10017 or contacted through representative Lilly-Rose Paraskevas at (212) 803-6005.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Paraskevas Lilly-Rose MD through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.